Bernhard, Jürg; Dietrich, Daniel; Scheithauer, Werner; Gerber, Daniela; Bodoky, György; Ruhstaller, Thomas; Glimelius, Bengt; Bajetta, Emilio; Schüller, Johannes; Saletti, Piercarlo; Bauer, Jean; Figer, Arie; Pestalozzi, Bernhard C; Köhne, Claus-Henning; Mingrone, Walter; Stemmer, Salomon M; Tàmas, Karin; Kornek, Gabriela V; Koeberle, Dieter; Herrmann, Richard; ... (2008). Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001. Journal of clinical oncology, 26(22), pp. 3695-701. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2007.15.6240
Full text not available from this repository.To compare clinical benefit response (CBR) and quality of life (QOL) in patients receiving gemcitabine (Gem) plus capecitabine (Cap) versus single-agent Gem for advanced/metastatic pancreatic cancer.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Bernhard, Jürg Theodor |
ISSN: |
0732-183X |
Publisher: |
American Society of Clinical Oncology |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 15:24 |
Last Modified: |
02 Mar 2023 23:23 |
Publisher DOI: |
10.1200/JCO.2007.15.6240 |
PubMed ID: |
18669454 |
Web of Science ID: |
000258052100009 |
URI: |
https://boris.unibe.ch/id/eprint/37814 (FactScience: 211447) |
Actions (login required)
 |
Edit item |